Get started
Author

Fleur Hudson

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
2009 · John Collinge, Michele Gorham, et al. · The Lancet Neurology · 262
PDF
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
2017 · Guy E Thwaites, Matthew Scarborough, et al. · The Lancet · 199
PDF
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
2021 · Wesley H. Self, Uriel Sandkovsky, et al. · The Lancet Infectious Diseases · 190
PDF
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
2014 · François Raffi, Abdel G Babiker, et al. · The Lancet · 179
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
2020 · Sarah Fidler, Wolfgang Stöhr, et al. · The Lancet · 136
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
2019 · Richard T Davey, Eduardo Fernández-Cruz, et al. · The Lancet Respiratory Medicine · 127
PDF
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123
PDF
TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe
2022 · Steven Y C Tong, Jocelyn Mora, et al. · Clinical Infectious Diseases · 107
PDF
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
2022 · Mark N. Polizzotto, Jacqueline Nordwall, et al. · The Lancet · 77
PDF
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels
2021 · ACTIV-3/TICO Bamlanivimab Study Group*, Jens D. Lundgren, et al. · Annals of Internal Medicine · 77
PDF
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
2019 · On behalf of past and present members of the STAMPEDE and FOCUS4 Trial Management Group, Francesca Schiavone, et al. · Trials · 61
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
A randomized trial comparing concise and standard consent forms in the START trial
2017 · Christine Grady, Giota Touloumi, et al. · PLoS ONE · 42
PDF
Occurrence of Accelerated Epigenetic Aging and Methylation Disruptions in Human Immunodeficiency Virus Infection Before Antiretroviral Therapy
2020 · Chen Xi Yang, Emma Schon, et al. · The Journal of Infectious Diseases · 38
PDF
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
2023 · Tom Foltynie, Sonia Gandhi, et al. · Brain · 34
PDF
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
2021 · Daniel D Murray, Abdel G Babiker, et al. · Clinical Trials · 33
PDF
DNA methylation is associated with airflow obstruction in patients living with HIV
2020 · Ana I Hernandez Cordero, Chen Xi Yang, et al. · Thorax · 33
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
PRION-1 scales analysis supports use of functional outcome measures in prion disease
2011 · S. Mead, M. Ranopa, et al. · Neurology · 30
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
2025 · Silke Gillessen, Silke Gillessen, et al. · The Lancet Oncology · 26
PDF
The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study
2022 · Ana I Hernández Cordero, Chen Xi Yang, et al. · EBioMedicine · 21
PDF
Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials
2016 · Gregg S Larson, Cate Carey, et al. · Clinical Trials · 21
Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial
2011 · Mark Holodniy, Sheldon T. Brown, et al. · PLoS ONE · 20
PDF
Health-Related Quality of Life Outcomes in HIV-Infected Patients Starting Different Combination Regimens in a Randomized Multinational Trial: The INITIO-QoL Substudy
2007 · Raffaella Bucciardini, Vincenzo Fragola, et al. · AIDS Research and Human Retroviruses · 20
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19
PDF
Works count: 63
Citation count: 2,048
H-index: 20
I10-index: 34
Year
Topic
Type